Glaukos Eyes IPO As Life Sciences Hit Rough Patch
Venture capital-backed glaucoma treatment maker Glaukos Corp. joined the initial public offering pipeline on Tuesday, marking the second life sciences company to file its plans this week despite a recent flurry...To view the full article, register now.
Already a subscriber? Click here to view full article